Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for istradefylline in Related Substance Name (approximate match)

Showing 1 - 10 of 19 results

First page disabled
Previous page disabled
1
Next page
Next page

ISTRADEFYLLINE

2GZ0LIK7T4

Search for Structure

Status:

US Approved Rx (2019)

Source:

NDA022075

(2019)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022075

First approved in 2019

Source:

NDA022075

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022075

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Adenosine A2a receptor

Conditions:

Parkinson's disease

Istradefylline is a first-in-class adenosine A2A receptor antagonist antiparkinsonian agent and has been marketed as the brand name NOURIAST® in Japan since May 30, 2013. NOURIAST is indicated for the improvement of wearing-off phenomena in patients with Parkinson’s disease on concomitant treatment with levodopa-containing products.

1-BETA-HYDROXYLATED-3',4'-O-DIDEMETHYL-HYDROGENATED ISTRADEFYLLINE

PGF0X8X1QD

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

1-DEETHYL-3',4'-O-DIDEMETHYL-HYDROGENATED ISTRADEFYLLINE

YV1C905XYF

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

4'-O-DEMETHYL-HYDROGENATED ISTRADEFYLLINE GLUCURONIDE

O303YH07AQ

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

3',4'-O-DIDEMETHYL-HYDROGENATED ISTRADEFYLLINE

U2HD5M3WR7

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

1-BETA-HYDROXYLATED ISTRADEFYLLINE

4198IAF0OH

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

3',4'-O-DIDEMETHYL-1-BETA CARBOXYLATED HYDROGENATED ISTRADEFYLLINE

G2E7E4E4HK

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

4'-O-DEMETHYL ISTRADEFYLLINE

I2P9NA76OG

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

1-BETA-CARBOXYLATED ISTRADEFYLLINE

5EM6OCN637

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

PLASMA PROTEIN FRACTION (HUMAN)

6D53G0FD0Z

Status:

US Approved Rx (2013)

Source:

BLA125416

(2013)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 1958

Source:

BLA101140

Source URL:

https://www.fda.gov/media/113210/download

Class:

MIXTURE

Structure of ISTRADEFYLLINE

ACHIRAL

Structure of 1-BETA-HYDROXYLATED-3',4'-O-DIDEMETHYL-HYDROGENATED ISTRADEFYLLINE

ACHIRAL

1-BETA-HYDROXYLATED-3',4'-O-DIDEMETHYL-HYDROGENATED ISTRADEFYLLINE

Structure of 1-DEETHYL-3',4'-O-DIDEMETHYL-HYDROGENATED ISTRADEFYLLINE

ACHIRAL

1-DEETHYL-3',4'-O-DIDEMETHYL-HYDROGENATED ISTRADEFYLLINE

Structure of 4'-O-DEMETHYL-HYDROGENATED ISTRADEFYLLINE GLUCURONIDE

ABSOLUTE

4'-O-DEMETHYL-HYDROGENATED ISTRADEFYLLINE GLUCURONIDE

Structure of 3',4'-O-DIDEMETHYL-HYDROGENATED ISTRADEFYLLINE

ACHIRAL

3',4'-O-DIDEMETHYL-HYDROGENATED ISTRADEFYLLINE

Structure of 1-BETA-HYDROXYLATED ISTRADEFYLLINE

ACHIRAL

1-BETA-HYDROXYLATED ISTRADEFYLLINE

Structure of 3',4'-O-DIDEMETHYL-1-BETA CARBOXYLATED HYDROGENATED ISTRADEFYLLINE

ACHIRAL

3',4'-O-DIDEMETHYL-1-BETA CARBOXYLATED HYDROGENATED ISTRADEFYLLINE

Structure of 4'-O-DEMETHYL ISTRADEFYLLINE

ACHIRAL

4'-O-DEMETHYL ISTRADEFYLLINE

Structure of 1-BETA-CARBOXYLATED ISTRADEFYLLINE

ACHIRAL

1-BETA-CARBOXYLATED ISTRADEFYLLINE

6D53G0FD0Z
Not a public record

Mixture

PLASMA PROTEIN FRACTION (HUMAN)

Showing 1 - 10 of 19 results

First page disabled
Previous page disabled
1
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1